SCHEMBL279762

SCHEMBL279762

CCCCCc1cc(O)c2c(c1)OC(F)(F)C1CCC(C)=CC21

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 16/20 0.79
CNR1 P21554 12/20 0.79
ABHD12 Q8N2K0 3/20 0.79
ABHD6 Q9BV23 3/20 0.79
FAAH O00519 2/20 0.79
TRPM8 Q7Z2W7 2/20 0.79
GPR55 Q9Y2T6 2/20 0.79
NR1I2 O75469 1/20 0.79
LDHA P00338 1/20 0.79
GLRA1 P23415 1/20 0.79
GPR183 P32249 1/20 0.79
DRD3 P35462 1/20 0.79
ENPP2 Q13822 1/20 0.79
GPR18 Q14330 1/20 0.79
KDR P35968 1/20 0.68
TRPA1 O75762 1/20 0.67
HTR1A P08908 1/20 0.67
TRPV1 Q8NER1 1/20 0.67
TRPV3 Q8NET8 1/20 0.67
TRPV6 Q9H1D0 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dronabinol SCHEMBL29390424 0.88 CNR2 (1.00) CNR2CNR1ABHD12ABHD6FAAH
Dronabinol SCHEMBL11375978 0.88 CNR2 (1.00) CNR2CNR1ABHD12ABHD6FAAH
Dronabinol SCHEMBL13394311 0.88 CNR2 (1.00) CNR2CNR1ABHD12ABHD6FAAH
Dronabinol SCHEMBL1227386 0.88 CNR2 (1.00) CNR2CNR1ABHD12ABHD6FAAH
Dronabinol SCHEMBL13214137 0.88 CNR2 (1.00) CNR2CNR1ABHD12ABHD6FAAH
Dronabinol SCHEMBL24702729 0.88 CNR2 (1.00) CNR2CNR1ABHD12ABHD6FAAH
Dronabinol SCHEMBL3686519 0.88 CNR2 (1.00) CNR2CNR1ABHD12ABHD6FAAH
Dronabinol SCHEMBL4609 0.88 CNR2 (1.00) CNR2CNR1ABHD12ABHD6FAAH
Dronabinol SCHEMBL22705549 0.88 CNR2 (1.00) CNR2CNR1ABHD12ABHD6FAAH
Dronabinol SCHEMBL29422026 0.88 CNR2 (1.00) CNR2CNR1ABHD12ABHD6FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8133887-B2 Oxaphenanthrene derivatives MERCK PATENT GMBH (DE) 2012-03-13 US disclosed
EP-1963299-B1 OXAPHENANTHRENE DERIVATIVES MERCK PATENT GMBH (DE) 2012-01-18 EP disclosed
US-20080312224-A1 Oxaphenanthrene Derivatives MERCK PATENT GMBH (DE) 2008-12-18 US disclosed
WO-2007079830-A1 OXAPHENANTHRENE DERIVATIVES MERCK PATENT GMBH (DE) 2007-07-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312224-A1 Oxaphenanthrene Derivatives CYP3A43, CYP1A1, CYP1A2 CNR2 1588/4885CNR1 1123/4885ABHD12 4732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.